{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:02:44Z","timestamp":1790164964217,"version":"4.1.0"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacasi.2026.06.030","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:17:20Z","timestamp":1786493840000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["HFpEF in Asia"],"prefix":"10.1016","author":[{"given":"Elena Alina","family":"Balasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Capone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Fioretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Catena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Tromp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8079-4618","authenticated-orcid":false,"given":"Roger S.Y.","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0852-0767","authenticated-orcid":false,"given":"Yibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.P.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7582-7171","authenticated-orcid":false,"given":"Gabriele G.","family":"Schiattarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacasi.2026.06.030_bib1","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction: JACC scientific statement","volume":"81","author":"Borlaug","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib2","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","article-title":"Global epidemiology of heart failure","volume":"21","author":"Khan","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ejhf.1227","article-title":"Heart failure with preserved ejection fraction in Asia","volume":"21","author":"Tromp","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012199","article-title":"Regional variation of mortality in heart failure with reduced and preserved ejection fraction across Asia: outcomes in the ASIAN-HF registry","volume":"9","author":"MacDonald","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacasi.2026.06.030_bib6","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1093\/eurheartj\/ehw331","article-title":"Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry","volume":"37","author":"Lam","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2026.06.030_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cardfail.2022.09.018","article-title":"Epidemiology, pathophysiology, diagnosis, and therapy of heart failure with preserved ejection fraction in Japan","volume":"29","author":"Obokata","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jchf.2024.01.015","article-title":"Utility and validity of the HFA-PEFF and H2FPEF scores in patients with symptomatic atrial fibrillation","volume":"12","author":"Ariyaratnam","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib11","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J \u2013 Cardiovasc Imaging"},{"key":"10.1016\/j.jacasi.2026.06.030_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamacardio.2022.1916","article-title":"Diagnosis of heart failure with preserved ejection fraction among patients with unexplained dyspnea","volume":"7","author":"Reddy","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/ejhf.1741","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA\u2013PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"22","author":"Pieske","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib15","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/s41591-024-03140-1","article-title":"An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA score","volume":"30","author":"Reddy","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jacasi.2026.06.030_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2021.08.001","article-title":"Performance of the H2FPEF and the HFA-PEFF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients: a report from the Japanese multicenter registry","volume":"342","author":"Tada","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jjcc.2025.03.018","article-title":"An evidence-based tool for screening for heart failure with preserved ejection fraction in primary care: the BREATH2 score","volume":"86","author":"Saito","year":"2025","journal-title":"J Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jjcc.2026.03.012","article-title":"Clinical utility of the BREATH score for heart failure risk stratification in patients with atrial fibrillation","volume":"88","author":"Saito","year":"2026","journal-title":"J Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1253\/circj.CJ-25-0214","article-title":"Diagnostic approaches to heart failure with preserved ejection fraction (HFpEF) - identification of unrecognized HFpEF","volume":"89","author":"Okuno","year":"2025","journal-title":"Circ J"},{"key":"10.1016\/j.jacasi.2026.06.030_bib20","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2026.06.030_bib21","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.124.072156","article-title":"Evidence-based application of natriuretic peptides in the evaluation of chronic heart failure with preserved ejection fraction in the ambulatory outpatient setting","volume":"151","author":"Reddy","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib22","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2026.06.030_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.amjcard.2022.02.037","article-title":"Secular trends in prevalence of heart failure diagnosis over 20 years (from the US NHANES)","volume":"172","author":"Siontis","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib24","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1001\/jama.296.18.2209","article-title":"Systolic and diastolic heart failure in the community","volume":"296","author":"Bursi","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacasi.2026.06.030_bib25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacasi.2026.06.030_bib26","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jchf.2018.03.006","article-title":"Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Tsao","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib27","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/01.CIR.98.21.2282","article-title":"Congestive heart failure in the community","volume":"98","author":"Senni","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005652","article-title":"Heart failure with preserved ejection fraction infrequently evolves toward a reduced phenotype in long-term survivors: a long-term prospective longitudinal study","volume":"12","author":"Lup\u00f3n","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib29","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","article-title":"Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction","volume":"64","author":"Mentz","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib30","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/eurjhf\/hfr064","article-title":"Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-international registry","volume":"13","author":"West","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib31","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00392-019-01430-0","article-title":"Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs preserved ejection fraction: a study using the Swedish heart failure registry","volume":"108","author":"Ergatoudes","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib32","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib33","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/ijerph13080770","article-title":"Prevalence and risk factors of heart failure with preserved ejection fraction: a population-based study in Northeast China","volume":"13","author":"Guo","year":"2016","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jacasi.2026.06.030_bib34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cardfail.2011.09.003","article-title":"Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International\u2013Asia Pacific)","volume":"18","author":"Atherton","year":"2012","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2015.11.183","article-title":"Heart failure in Africa, Asia, the Middle East and South America: the INTER-CHF study","volume":"204","author":"Dokainish","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1253\/circj.CJ-11-0135","article-title":"Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan: \u2013 first report from the CHART-2 study","volume":"75","author":"Shiba","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.jacasi.2026.06.030_bib37","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1253\/circj.CJ-18-0073","article-title":"Clinical characteristics, management, and outcomes of Japanese patients hospitalized for heart failure with preserved ejection fraction \u2014 A report from the Japanese heart failure syndrome with preserved ejection fraction (JASPER) registry","volume":"82","author":"Nagai","year":"2018","journal-title":"Circ J"},{"key":"10.1016\/j.jacasi.2026.06.030_bib38","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1253\/circj.CJ-09-73-1203","article-title":"Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD)","volume":"73","author":"Tsuchihashi-Makaya","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.jacasi.2026.06.030_bib39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ehf2.14162","article-title":"Aetiology of chronic heart failure in patients from a super-aged Society: the KUNIUMI registry chronic cohort","volume":"10","author":"Fujimoto","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib40","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/ejhf.2654","article-title":"Clinical characteristics and 1-year outcomes in hospitalized patients with heart failure with preserved ejection fraction: results from the China Cardiovascular Association Database-Heart Failure Center Registry","volume":"24","author":"Cai","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib41","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ejhf.283","article-title":"Clinical presentation, management, in-hospital and 90-day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum heart failure registry","volume":"17","author":"Harikrishnan","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib42","first-page":"908","article-title":"The Cardiology Society of India-Kerala Acute Heart Failure Registry: poor adherence to guideline-directed medical therapy","volume":"43","author":"Joseph","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2026.06.030_bib43","article-title":"Multimorbidity in patients with heart failure from 11 Asian regions: a prospective cohort study using the ASIAN-HF registry","volume":"15","author":"Tromp","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacasi.2026.06.030_bib44","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/ejhf.1629","article-title":"Prevalence of heart failure and left ventricular dysfunction in China: the China hypertension survey, 2012\u20132015","volume":"21","author":"Hao","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ehf2.12418","article-title":"Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan","volume":"6","author":"Shiga","year":"2019","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib46","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1161\/CIRCULATIONAHA.118.034720","article-title":"Heart failure with preserved ejection fraction in the young","volume":"138","author":"Tromp","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib48","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/dom.15238","article-title":"Prevalence of obesity and associated complications in China: a cross-sectional, real-world study in 15.8 million adults","volume":"25","author":"Chen","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacasi.2026.06.030_bib49","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2213-8587(23)00119-5","article-title":"Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)","volume":"11","author":"Anjana","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib50","doi-asserted-by":"crossref","first-page":"e665","DOI":"10.1016\/S2214-109X(17)30196-1","article-title":"Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study","volume":"5","author":"Dokainish","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jacasi.2026.06.030_bib51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and In-Hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function","volume":"47","author":"Yancy","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib52","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/ejhf.3445","article-title":"Heart failure in Europe: guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction \u2013 the ESC EORP Heart Failure III Registry","volume":"26","author":"Lund","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Anon. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2026.06.030_bib54","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007901","article-title":"Global differences in heart failure with preserved ejection fraction: the PARAGON-HF trial","volume":"14","author":"Tromp","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib55","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cardfail.2024.08.042","article-title":"Racial differences of cardiac structure and function in heart failure with preserved ejection fraction","volume":"31","author":"Sorimachi","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib56","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib57","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly Male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.110.979203","article-title":"Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community","volume":"124","author":"Lam","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib59","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2026.06.030_bib60","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ejhf.1671","article-title":"Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction","volume":"22","author":"Yang","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib61","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.120.045810","article-title":"Proteomic evaluation of the comorbidity-inflammation paradigm in heart failure with preserved ejection fraction","volume":"142","author":"Sanders-van Wijk","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib62","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001633","article-title":"Inflammatory biomarkers predict heart failure severity and prognosis in patients with heart failure with preserved ejection fraction","volume":"10","author":"Hage","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacasi.2026.06.030_bib63","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1152\/physrev.00030.2020","article-title":"Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications","volume":"101","author":"Ren","year":"2021","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jacasi.2026.06.030_bib64","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.3390\/diagnostics14232677","article-title":"Adipokines and cardiometabolic heart failure with preserved ejection fraction: a state-of-the-art review","volume":"14","author":"Theodorakis","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.jacasi.2026.06.030_bib65","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/cvr\/cvaf056","article-title":"The role of epicardial adipose tissue remodelling in heart failure with preserved ejection fraction","volume":"121","author":"Janssen-Telders","year":"2025","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib66","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/01.CIR.104.2.215","article-title":"Load versus humoral activation in the genesis of early hypertensive heart disease","volume":"104","author":"Hart","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib67","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/FJC.0b013e3181d89670","article-title":"Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease","volume":"55","author":"Cohen","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib68","article-title":"Routine stress testing with subsequent coronary angiography versus standard of care in high-risk patients after percutaneous coronary intervention: an updated meta-analysis of randomized controlled trials","volume":"58","author":"Adamu","year":"2025","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jacasi.2026.06.030_bib69","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/CIRCULATIONAHA.110.014506","article-title":"Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus","volume":"124","author":"Shenouda","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib70","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/CIRCRESAHA.124.325488","article-title":"Renal-cardiac crosstalk in the pathogenesis and progression of heart failure","volume":"136","author":"Noels","year":"2025","journal-title":"Circ Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib71","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2026.06.030_bib72","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/ejhf.1902","article-title":"Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease","volume":"22","author":"Packer","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib73","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","article-title":"Metabolic inflammation in heart failure with preserved ejection fraction","volume":"117","author":"Schiattarella","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib74","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","article-title":"Low myocardial protein kinase G activity in heart failure with preserved ejection fraction","volume":"126","author":"van Heerebeek","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib75","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","article-title":"Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction","volume":"4","author":"Westermann","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib76","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/cvr\/cvag084","article-title":"Integrated left ventricular multi-omics landscape of human cardiometabolic HFpEF","volume":"122","author":"Capone","year":"2026","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib77","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jchf.2020.04.007","article-title":"Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis","volume":"8","author":"Hahn","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib78","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jacc.2019.12.069","article-title":"Multiple plasma biomarkers for risk stratification in patients with heart failure and preserved ejection fraction","volume":"75","author":"Chirinos","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib79","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.12.045","article-title":"Inflammatory markers and incident heart failure risk in older adults: the health ABC (Health, Aging, and Body Composition) study","volume":"55","author":"Kalogeropoulos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1461073","article-title":"Association of systemic inflammatory markers with clinical adverse prognosis and outcomes in HFpEF: a systematic review and meta-analysis of cohort studies","volume":"11","author":"Fu","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacasi.2026.06.030_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24226-1","article-title":"Protein biomarkers of cardiac remodeling and inflammation associated with HFpEF and incident events","volume":"12","author":"Regan","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacasi.2026.06.030_bib82","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41423-021-00804-7","article-title":"Resident and migratory adipose immune cells control systemic metabolism and thermogenesis","volume":"19","author":"Man","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib83","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacasi.2026.06.030_bib84","first-page":"637","article-title":"The macrophage switch in obesity development","volume":"6","author":"Castoldi","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.54","article-title":"Local proliferation initiates macrophage accumulation in adipose tissue during obesity","volume":"7","author":"Zheng","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jacasi.2026.06.030_bib86","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41569-023-00964-1","article-title":"Immune and inflammatory mechanisms in hypertension","volume":"21","author":"Guzik","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133161","article-title":"Non-classical monocytes are associated with functional markers of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction","volume":"429","author":"Kessler","year":"2025","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib88","doi-asserted-by":"crossref","first-page":"H109","DOI":"10.1152\/ajpheart.00022.2025","article-title":"CCR2+ monocyte-derived macrophages drive cardiac hypertrophy in early HFpEF","volume":"329","author":"Raman","year":"2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib89","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.20171274","article-title":"Cardiac macrophages promote diastolic dysfunction","volume":"215","author":"Hulsmans","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.jacasi.2026.06.030_bib90","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.121.318159","article-title":"From systemic inflammation to myocardial fibrosis","volume":"128","author":"Paulus","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib91","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib92","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1093\/eurheartj\/ehy712","article-title":"Novel endotypes in heart failure: effects on guideline-directed medical therapy","volume":"39","author":"Tromp","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2026.06.030_bib93","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006414","article-title":"Obese-inflammatory phenotypes in heart failure with preserved ejection fraction","volume":"13","author":"Sabbah","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.614757","article-title":"High neutrophil to lymphocyte ratio and its gene signatures correlate with diastolic dysfunction in heart failure with preserved ejection fraction","volume":"8","author":"Bai","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacasi.2026.06.030_bib95","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1002\/ehf2.13071","article-title":"Pathophysiological role of fatty acid-binding protein 4 in Asian patients with heart failure and preserved ejection fraction","volume":"7","author":"Harada","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib96","article-title":"Association between omentin-1 and heart failure with preserved ejection fraction in Chinese elderly patients","volume":"47","author":"Su","year":"2023","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib97","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1002\/ehf2.14808","article-title":"Relationship of interleukin-16 with different phenogroups in acute heart failure with preserved ejection fraction","volume":"11","author":"Tamaki","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib98","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s44161-022-00032-w","article-title":"Immunometabolic mechanisms of heart failure with preserved ejection fraction","volume":"1","author":"Schiattarella","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib99","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.jacc.2021.04.003","article-title":"Pericardial fat and the risk of heart failure","volume":"77","author":"Kenchaiah","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib100","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib101","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4049\/jimmunol.1401024","article-title":"Adenosine 5\u2019-monophosphate-activated protein kinase regulates IL-10-mediated anti-inflammatory signaling pathways in macrophages","volume":"194","author":"Zhu","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib102","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/BST20220271","article-title":"ERK1\/2 in immune signalling","volume":"50","author":"Lucas","year":"2022","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jacasi.2026.06.030_bib103","doi-asserted-by":"crossref","first-page":"H984","DOI":"10.1152\/ajpheart.00428.2011","article-title":"Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling","volume":"301","author":"Essick","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib104","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2019.11.044","article-title":"Cardiometabolic-based chronic disease, adiposity and dysglycemia drivers: JACC state-of-the-art review","volume":"75","author":"Mechanick","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib105","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","article-title":"Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes","volume":"113","author":"Kolwicz","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib106","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/cvr\/cvx012","article-title":"Inflammation and metabolic cardiomyopathy","volume":"113","author":"Nishida","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib107","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41569-026-01257-z","article-title":"HFpEF and MASLD: converging mechanisms and clinical implications","volume":"23","author":"Capone","year":"2026","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib108","article-title":"Unmasking heterogeneity in metabolic syndrome in a national sample of disaggregated Asian American subgroups","volume":"16","author":"Zhu","year":"2025","journal-title":"Obes Pillars"},{"key":"10.1016\/j.jacasi.2026.06.030_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2026.101509","article-title":"Body mass index threshold for obesity should be personalized based on polygenic score: analysis of European and East Asian Biobanks","volume":"29","author":"Kim","year":"2026","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib110","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3945\/ajcn.112.035758","volume":"96","author":"Nazare","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacasi.2026.06.030_bib111","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/j.gastro.2018.11.021","article-title":"Propensity for intra-abdominal and hepatic adiposity varies among ethnic groups","volume":"156","author":"Lim","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacasi.2026.06.030_bib112","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1038\/nutd.2011.2","article-title":"Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index","volume":"1","author":"Lim","year":"2011","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.jacasi.2026.06.030_bib113","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S2213-8587(24)00195-5","article-title":"Adiposity and metabolic health in Asian populations: an epidemiological study using dual-energy x-ray absorptiometry in Singapore","volume":"12","author":"Mina","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib114","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.jacasi.2025.07.017","article-title":"Obesity-related Asian patients with heart failure with preserved ejection fraction","volume":"5","author":"Kagami","year":"2025","journal-title":"JACC Asia"},{"key":"10.1016\/j.jacasi.2026.06.030_bib115","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jacc.2016.03.610","article-title":"When an increase in central systolic pressure overrides the benefits of heart rate lowering","volume":"68","author":"Messerli","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib116","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/341583","article-title":"Relevance of sympathetic nervous system activation in obesity and metabolic syndrome","volume":"2015","author":"Thorp","year":"2015","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib117","doi-asserted-by":"crossref","first-page":"H331","DOI":"10.1152\/ajpheart.00274.2020","article-title":"Pressure overload generates a cardiac-specific profile of inflammatory mediators","volume":"319","author":"O\u2019Brien","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib118","article-title":"Heart failure and type 2 diabetes mellitus: neurohumoral, histological and molecular interconnections","volume":"19","author":"Ushakov","year":"2023","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.jacasi.2026.06.030_bib119","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib120","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10741-024-10439-1","article-title":"Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities","volume":"30","author":"Vacca","year":"2025","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacasi.2026.06.030_bib121","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.125.012674","article-title":"Cellular interactions and immunometabolic mechanisms in heart failure with preserved ejection fraction: from molecular mechanisms to clinical evidence","volume":"19","author":"Peikert","year":"2026","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib122","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacasi.2026.06.030_bib123","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcmg.2015.02.014","article-title":"Ethnic-specific normative reference values for echocardiographic LA and LV size, LV mass, and systolic function: the EchoNoRMAL study","volume":"8","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacasi.2026.06.030_bib124","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11897-013-0166-4","article-title":"Ventricular remodeling in heart failure with preserved ejection fraction","volume":"10","author":"Shah","year":"2013","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacasi.2026.06.030_bib125","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1161\/CIRCULATIONAHA.110.011031","article-title":"Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction","volume":"124","author":"Zile","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib126","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.amjcard.2013.05.061","article-title":"Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction","volume":"112","author":"Katz","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib127","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCHEARTFAILURE.113.000887","article-title":"Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial","volume":"7","author":"Shah","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib128","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jacc.2018.11.033","article-title":"Heart failure with preserved ejection fraction and diabetes: JACC state-of-the-art review","volume":"73","author":"McHugh","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib129","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jcmg.2009.10.012","article-title":"The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"3","author":"Turkbey","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacasi.2026.06.030_bib130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2337\/db15-0627","article-title":"Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes","volume":"65","author":"Levelt","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jacasi.2026.06.030_bib131","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib132","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jacc.2009.09.065","article-title":"Sex-related differences in myocardial remodeling","volume":"55","author":"Piro","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib133","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ejhf.67","article-title":"Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction","volume":"16","author":"Gori","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib134","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIRCULATIONAHA.106.659763","article-title":"Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota","volume":"115","author":"Lam","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib135","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1016\/j.jacc.2019.09.063","article-title":"Echocardiographic features of patients with heart failure and preserved left ventricular ejection fraction","volume":"74","author":"Shah","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib136","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1161\/CIRCULATIONAHA.108.826230","article-title":"Microarray identifies extensive downregulation of noncollagen extracellular matrix and profibrotic growth factor genes in chronic isolated mitral regurgitation in the dog","volume":"119","author":"Zheng","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib137","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCULATIONAHA.117.029858","article-title":"Early detection of subclinical myocardial damage in chronic aortic regurgitation and strategies for timely treatment of asymptomatic patients","volume":"137","author":"Lee","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib138","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.2000.278.1.H151","article-title":"Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control","volume":"278","author":"Nagatomo","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib139","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial","volume":"380","author":"Solomon","year":"2012","journal-title":"The Lancet"},{"key":"10.1016\/j.jacasi.2026.06.030_bib140","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.amjcard.2008.11.050","article-title":"Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%","volume":"103","author":"He","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib141","article-title":"Cardiac remodeling and functional alterations in heart failure with preserved ejection fraction (HFpEF): an echocardiographic assessment at a tertiary hospital in Bangladesh","volume":"17","author":"Rahman","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.jacasi.2026.06.030_bib142","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cardfail.2013.01.007","article-title":"The Singapore heart failure outcomes and phenotypes (SHOP) study and prospective evaluation of outcome in patients with heart failure with preserved left ventricular ejection fraction (PEOPLE) study: rationale and design","volume":"19","author":"Santhanakrishnan","year":"2013","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib143","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/jcm15010163","article-title":"Multimodality imaging in cardiac amyloidosis","volume":"15","author":"Chaudhari","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacasi.2026.06.030_bib144","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCIMAGING.113.000633","article-title":"Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction","volume":"6","author":"Mascherbauer","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacasi.2026.06.030_bib145","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jamacardio.2017.2511","article-title":"Temporal relation between myocardial fibrosis and heart failure with preserved ejection fraction: association with baseline disease severity and subsequent outcome","volume":"2","author":"Schelbert","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib146","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41569-020-00504-1","article-title":"Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches","volume":"18","author":"L\u00f3pez","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib147","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.recesp.2016.12.018","article-title":"Role of myocardial collagen in severe aortic stenosis with preserved ejection fraction and symptoms of heart failure","volume":"70","author":"Echegaray","year":"2017","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib148","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jacasi.2026.06.030_bib149","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.jacc.2020.02.041","article-title":"AntimiR-21 prevents myocardial dysfunction in a pig model of ischemia\/reperfusion injury","volume":"75","author":"Hinkel","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib150","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41467-020-14349-2","article-title":"Preclinical development of a miR-132 inhibitor for heart failure treatment","volume":"11","author":"Foinquinos","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacasi.2026.06.030_bib151","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib152","doi-asserted-by":"crossref","first-page":"26","DOI":"10.12997\/jla.2019.8.1.26","article-title":"Established and emerging mechanisms of diabetic cardiomyopathy","volume":"8","author":"Gollmer","year":"2019","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.jacasi.2026.06.030_bib153","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13098-025-01783-9","article-title":"The role of myocardial fibrosis in the diabetic cardiomyopathy","volume":"17","author":"Sun","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jacasi.2026.06.030_bib154","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/01.HYP.36.2.220","article-title":"Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease","volume":"36","author":"Schwartzkopff","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.jacasi.2026.06.030_bib156","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002649","article-title":"Impairment of coronary flow reserve evaluated by phase contrast cine-magnetic resonance imaging in patients with heart failure with preserved ejection fraction","volume":"5","author":"Kato","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacasi.2026.06.030_bib157","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1161\/01.CIR.83.5.1771","article-title":"Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy","volume":"83","author":"Brilla","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib158","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.jacc.2014.01.068","article-title":"Therapeutic targets in heart failure: refocusing on the myocardial interstitium","volume":"63","author":"Schelbert","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib159","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.jcmg.2020.05.030","article-title":"Myocardial native T1 predicts load-independent left ventricular chamber stiffness in patients with HFpEF","volume":"13","author":"Omori","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacasi.2026.06.030_bib160","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jacc.2021.12.017","article-title":"Inflammation, aging, and cardiovascular disease","volume":"79","author":"Liberale","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib161","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging: an evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jacasi.2026.06.030_bib162","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/nm.3998","article-title":"The metabolic regulation of aging","volume":"21","author":"Finkel","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jacasi.2026.06.030_bib163","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yjmcc.2019.01.015","article-title":"Pre-existing fibroblasts of epicardial origin are the primary source of pathological fibrosis in cardiac ischemia and aging","volume":"129","author":"Quijada","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib164","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jacc.2008.01.011","article-title":"Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction","volume":"51","author":"Bujak","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib165","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbrc.2014.08.109","article-title":"Ageing related periostin expression increase from cardiac fibroblasts promotes cardiomyocytes senescent","volume":"452","author":"Li","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacasi.2026.06.030_bib166","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1057349","article-title":"A potential role of autophagy-mediated vascular senescence in the pathophysiology of HFpEF","volume":"13","author":"Sanhueza-Olivares","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib167","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003806","article-title":"Endothelial senescence contributes to heart failure with preserved ejection fraction in an aging mouse model","volume":"10","author":"Gevaert","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.030_bib168","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.jacasi.2025.05.020","article-title":"Comprehensive introduction to ASIAN-HF registry","volume":"5","author":"Teng","year":"2025","journal-title":"JACC Asia"},{"key":"10.1016\/j.jacasi.2026.06.030_bib169","doi-asserted-by":"crossref","first-page":"7753","DOI":"10.1038\/s41467-022-35323-0","article-title":"Genetic architecture of heart failure with preserved versus reduced ejection fraction","volume":"13","author":"Joseph","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacasi.2026.06.030_bib171","doi-asserted-by":"crossref","first-page":"9680","DOI":"10.1038\/s41467-025-64659-6","article-title":"Genome-wide analysis of heart failure yields insights into disease heterogeneity and enables prognostic prediction in the Japanese population","volume":"16","author":"Enzan","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacasi.2026.06.030_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2023.100436","article-title":"Analysis across Taiwan Biobank, Biobank Japan, and UK Biobank identifies hundreds of novel loci for 36 quantitative traits","volume":"3","author":"Chen","year":"2023","journal-title":"Cell Genomics"},{"key":"10.1016\/j.jacasi.2026.06.030_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2023.110710","article-title":"A genome-wide association scan reveals novel loci for facial traits of Koreans","volume":"115","author":"Cho","year":"2023","journal-title":"Genomics"},{"key":"10.1016\/j.jacasi.2026.06.030_bib176","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12916-021-02122-1","article-title":"Modification effect of ideal cardiovascular health metrics on genetic association with incident heart failure in the China Kadoorie Biobank and the UK Biobank","volume":"19","author":"Yang","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.jacasi.2026.06.030_bib177","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s44161-024-00545-6","article-title":"Measured and genetically predicted protein levels and cardiovascular diseases in UK Biobank and China Kadoorie Biobank","volume":"3","author":"Lind","year":"2024","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib178","doi-asserted-by":"crossref","first-page":"11770","DOI":"10.1093\/nar\/gkad779","article-title":"A high-resolution haplotype-resolved reference panel constructed from the China Kadoorie Biobank study","volume":"51","author":"Yu","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib179","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s12872-023-03554-8","article-title":"Role of PPAR-related genes in chronic heart failure: evidence from large populations","volume":"23","author":"Ke","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacasi.2026.06.030_bib180","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.yjmcc.2008.03.021","article-title":"The PPAR trio: regulators of myocardial energy metabolism in health and disease","volume":"44","author":"Madrazo","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib181","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib182","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","article-title":"Cellular and molecular pathobiology of heart failure with preserved ejection fraction","volume":"18","author":"Mishra","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib183","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1676988","article-title":"Mitochondrial dysfunction as a therapeutic nexus in HFpEF: therapeutic target and pharmacological advances","volume":"16","author":"Yue","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib184","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11897-023-00585-2","article-title":"Heart failure and multimorbidity in Asia","volume":"20","author":"Ang","year":"2023","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacasi.2026.06.030_bib185","first-page":"5139","article-title":"Differential and predictive value of Galectin-3 and soluble suppression of Tumorigenicity-2 (sST2) in heart failure with preserved ejection fraction","volume":"24","author":"Cui","year":"2018","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"10.1016\/j.jacasi.2026.06.030_bib186","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12933-025-02738-0","article-title":"Circulating mediators linking cardiometabolic diseases to HFpEF: a mediation Mendelian randomization analysis","volume":"24","author":"Lin","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib187","first-page":"313","article-title":"Assessing inflammation in Chinese subjects with subtypes of heart failure: an observational study of the Chinese PLA hospital heart failure registry","volume":"16","author":"Liu","year":"2019","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.030_bib188","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.122.061846","article-title":"Myocardial metabolomics of human heart failure with preserved ejection fraction","volume":"147","author":"Hahn","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2026.06.030_bib189","article-title":"Adiposity and clinical outcomes in East Asian patients with heart failure and preserved ejection fraction","volume":"44","author":"Seki","year":"2023","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jacasi.2026.06.030_bib190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002916","article-title":"Association of obesity with heart failure outcomes in 11 Asian regions: a cohort study","volume":"16","author":"Chandramouli","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacasi.2026.06.030_bib191","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jacasi.2024.01.013","article-title":"Epidemiology and burden of heart failure in Asia","volume":"4","author":"Feng","year":"2024","journal-title":"JACC Asia"},{"key":"10.1016\/j.jacasi.2026.06.030_bib192","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1186\/s12864-024-10575-w","article-title":"Integrated proteomic and metabolomic profiling reveals novel insights on the inflammation and immune response in HFpEF","volume":"25","author":"Abudurexiti","year":"2024","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jacasi.2026.06.030_bib193","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s12276-023-01028-7","article-title":"Immune regulation through tryptophan metabolism","volume":"55","author":"Seo","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jacasi.2026.06.030_bib194","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1253\/circj.CJ-16-0791","article-title":"Impact of plasma kynurenine level on functional capacity and outcome in heart failure - results from studies investigating Co-morbidities aggravating heart failure (SICA-HF)","volume":"81","author":"Konishi","year":"2016","journal-title":"Circ J"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374726005314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374726005314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:19:07Z","timestamp":1790162347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772374726005314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":191,"alternative-id":["S2772374726005314"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2026.06.030","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HFpEF in Asia","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2026.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}